Mergers & Acquisitions - Johnson & Johnson


Current filters:

Johnson & Johnson

Popular Filters

Johnson & Johnson offered $4.15 billion for its diagnostics unit

Johnson & Johnson offered $4.15 billion for its diagnostics unit


After days of speculation about divestitures by US health care major Johnson & Johnson, the company last…

Johnson & JohnsonMergers & AcquisitionsPharmaceutical

Johnson & Johnson in deal to buy Aragon Pharma for up to $1 billion


US health care giant Johnson & Johnson (NYSE: JNJ) has reached a definitive agreement to acquire Aragon…

Aragon PharmaceuticalsJohnson & JohnsonMergers & AcquisitionsOncologyPharmaceuticalSeragon Pharmaceuticals

Royalty bid for Elan could be withdrawn; J&J sells 25.4 million Elan shares


Ireland-based hostile takeover target Elan (NYSE: ELN) fell 5.2% to 9.29 euros on June 13, the most in…

ElanJohnson & JohnsonMergers & AcquisitionsPharmaceuticalRoyalty Pharma

Johnson & Johnson to set up innovation centers to accelerate partnering


US health care giant Johnson & Johnson (NYSE: JNJ) yesterday said it plans to establish four regional…

Johnson & JohnsonLicensingMergers & AcquisitionsPharmaceuticalResearch

Janssen buys Germany's CorImmun


US health care giant Johnson & Johnson's (NYSE: JNJ) European subsidiary Janssen-Cilag GmbH yesterday…

Cardio-vascularCorImmun GmbHJanssenJohnson & JohnsonMergers & AcquisitionsPharmaceutical

US regulator puts conditions on Johnson & Johnson's proposed buy of Synthes


The US Federal Trade Commission will require health care giant Johnson & Johnson (NYSE: JNJ) to sell…

Johnson & JohnsonMergers & AcquisitionsNorth AmericaPharmaceuticalRegulationSynthes

EU Commission OKs J&J's buy of Synthes, but with conditions


The European Commission last week cleared under the EU Merger Regulation the proposed $21.3 billion acquisition…

Johnson & JohnsonMergers & AcquisitionsPharmaceuticalSynthes

Synthes acquisition by Johnson & Johnson delayed as EU Commission starts in-depth investigation


The planned $21.3 billion acquisition of orthopedic device maker Synthes (SYST: VX), which is listed…

Johnson & JohnsonMergers & AcquisitionsPharmaceuticalSynthes

Merck & Co to bank $175 million on selling its share of consumer JV with Johnson & Johnson


US drug giant Merck & Co (NYSE: MRK) said yesterday that it has sold its 50% interest in the Johnson…

Johnson & JohnsonMcNeilMerck & CoMergers & AcquisitionsNorth AmericaPharmaceutical

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top